Literature DB >> 10980135

Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features.

B C Bastian1, P E LeBoit, D Pinkel.   

Abstract

Spitz nevus is a benign melanocytic neoplasm that can be difficult or impossible to histologically distinguish from melanoma. We have recently described copy number increases of chromosome 11p in a subset of Spitz nevi. To study the molecular and histological features of this group, we studied 102 Spitz nevi for 11p copy number increases using fluorescence in situ hybridization (FISH) on tissue arrays. Copy number increases of at least threefold were found in 12 cases (11.8%) and involved the HRAS gene on chromosome 11p. Sequence analysis of HRAS showed frequent oncogenic mutations in cases with copy number increase (8/12 or 67%), contrasting with rare HRAS mutations in cases with normal HRAS copy numbers (1/21 or 5%, P: < 0.0001). Tumors with 11p copy number increases were larger, predominantly intradermal, had marked desmoplasia, characteristic cytological features, and had an infiltrating growth pattern. Proliferation rates in the majority of these cases were low to absent. HRAS activation by either mutation or copy number increase alone could explain several of the histological features that overlap with those of melanoma. We speculate that HRAS activation in the absence of co-operating additional genetic alterations drives the partially transformed melanocytes of these Spitz nevi into senescence or a stable growth arrest. Although there is no data suggesting that Spitz nevi with HRAS activation are at risk for progression to melanoma, future studies are warranted to assess their biological behavior more accurately.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10980135      PMCID: PMC1885704          DOI: 10.1016/S0002-9440(10)64609-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

Review 1.  Spitz nevi.

Authors:  E M Casso; C M Grin-Jorgensen; J M Grant-Kels
Journal:  J Am Acad Dermatol       Date:  1992-12       Impact factor: 11.527

2.  Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization.

Authors:  B C Bastian; P E LeBoit; H Hamm; E B Bröcker; D Pinkel
Journal:  Cancer Res       Date:  1998-05-15       Impact factor: 12.701

Review 3.  Activated ras. Yet another player in melanoma?

Authors:  M Herlyn; K Satyamoorthy
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

4.  Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma.

Authors:  A van Elsas; S F Zerp; S van der Flier; K M Krüse; C Aarnoudse; N K Hayward; D J Ruiter; P I Schrier
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

5.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

6.  Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin.

Authors:  B C Bastian; M Kashani-Sabet; H Hamm; T Godfrey; D H Moore; E B Bröcker; P E LeBoit; D Pinkel
Journal:  Cancer Res       Date:  2000-04-01       Impact factor: 12.701

Review 7.  A matter of life and cell death.

Authors:  G Evan; T Littlewood
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

8.  Melanoma resembling spindle and epithelioid cell nevus.

Authors:  M R Okun
Journal:  Arch Dermatol       Date:  1979-12

9.  A human gastric carcinoma contains a single mutated and an amplified normal allele of the Ki-ras oncogene.

Authors:  J L Bos; M Verlaan-de Vries; C J Marshall; G H Veeneman; J H van Boom; A J van der Eb
Journal:  Nucleic Acids Res       Date:  1986-02-11       Impact factor: 16.971

10.  Stability of c-K-ras amplification during progression in a patient with adenocarcinoma of the ovary.

Authors:  J E Filmus; R N Buick
Journal:  Cancer Res       Date:  1985-09       Impact factor: 12.701

View more
  70 in total

Review 1.  Melanoma: from mutations to medicine.

Authors:  Hensin Tsao; Lynda Chin; Levi A Garraway; David E Fisher
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

2.  Mechanisms of cell-cycle arrest in Spitz nevi with constitutive activation of the MAP-kinase pathway.

Authors:  Janet L Maldonado; Luika Timmerman; Jane Fridlyand; Boris C Bastian
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

3.  Absence of senescence-associated beta-galactosidase activity in human melanocytic nevi in vivo.

Authors:  Murray A Cotter; Scott R Florell; Sancy A Leachman; Douglas Grossman
Journal:  J Invest Dermatol       Date:  2007-05-24       Impact factor: 8.551

Review 4.  Growth factors and oncogenes as targets in melanoma: lost in translation?

Authors:  Lawrence Kwong; Lynda Chin; Stephan N Wagner
Journal:  Adv Dermatol       Date:  2007

Review 5.  A diagnostic algorithm for atypical spitzoid tumors: guidelines for immunohistochemical and molecular assessment.

Authors:  Jeong Hee Cho-Vega
Journal:  Mod Pathol       Date:  2016-04-22       Impact factor: 7.842

Review 6.  Through the looking glass and what you find there: making sense of comparative genomic hybridization and fluorescence in situ hybridization for melanoma diagnosis.

Authors:  Jayson Miedema; Aleodor A Andea
Journal:  Mod Pathol       Date:  2020-02-17       Impact factor: 7.842

Review 7.  The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia.

Authors:  Boris C Bastian
Journal:  Annu Rev Pathol       Date:  2014       Impact factor: 23.472

Review 8.  NRAS mutant melanoma: biological behavior and future strategies for therapeutic management.

Authors:  I V Fedorenko; G T Gibney; K S M Smalley
Journal:  Oncogene       Date:  2012-10-15       Impact factor: 9.867

9.  Melanoma: Stem cells, sun exposure and hallmarks for carcinogenesis, molecular concepts and future clinical implications.

Authors:  Athanassios Kyrgidis; Thrasivoulos-George Tzellos; Stefanos Triaridis
Journal:  J Carcinog       Date:  2010-04-01

10.  Evaluation of the clonal origin of multiple primary melanomas using molecular profiling.

Authors:  Irene Orlow; Diana V Tommasi; Bradley Bloom; Irina Ostrovnaya; Javier Cotignola; Urvi Mujumdar; Klaus J Busam; Achim A Jungbluth; Richard A Scolyer; John F Thompson; Bruce K Armstrong; Marianne Berwick; Nancy E Thomas; Colin B Begg
Journal:  J Invest Dermatol       Date:  2009-03-12       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.